In vivo anticancer activity of lysates from Trypanosoma cruzi of different genetic groups

Bulletin of Experimental Biology and Medicine

Volumn 142, Issue 4, 2006, Pages 470-473

  Batmonkh, Zetsegsaikhan ^a   Kallinikova, V D ^b   Pakhorukova, L V ^b   Kravtsov, E G ^a   Karpenko, L P ^a   Dalin, M V ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

Author keywords

Antitumoractivity; Clone; Lysate; Trypanosoma cruzi

Indexed keywords

PROTOZOAL PROTEIN; TRYPANOSOMA CRUZI LYSATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; EPIMASTIGOTE; GROWTH INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; STRAIN DIFFERENCE; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL EXTRACTS; MICE; TRYPANOSOMA CRUZI;

MUS; ONCORHYNCHUS MASOU; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 33947130711     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0395-6     Document Type: Article

References (4)

1. V. D. Kallinikova, Antitumor Characteristics of T. cruzi, a Flagellar Protozoon [in Russian], Moscow (2004).
2. Yu. S. Korshunov, I. A. Osmanov, V. D. Kallinikova, et al., Vestn. Rossiisk. Univers. Druzhby Narodov, No. 1, 77-80 (2005).
3. L. A. Sheklakova, V. D. Kallinikova, and L. P. Karpenko, Byull. Eksp. Biol. Med., 135, No. 1, 103-106 (2003).
4. L. A. Sheklakova, V. D. Kallinikova, L. P. Karpenko, and M. Tibayrinc, Biomed. Tekhnol., No. 16, 224-230 (2001).